How much does a box of Seleniso cost in the market?

Selinexor () is a novel nuclear export inhibitor used to treat multiple myeloma and certain types of lymphoma. The drug induces apoptosis in cancer cells by blocking the export of key proteins in cancer cells. At present, Seleniso has been officially launched in China and has been included in the national medical insurance directory, which has greatly reduced the financial burden on patients. Patients can purchase prescriptions through the hospital pharmacy under the guidance of a doctor.

In the domestic market, the selling price of Seleniso varies according to drug specifications and medical insurance policies in different regions. Generally speaking, the price of each box is about RMB 5,000 to more than RMB 10,000. After being included in medical insurance, the actual out-of-pocket amount of the patient may drop significantly, and the reimbursement ratio is higher in some areas. It is recommended that patients go to the local medical insurance designated hospital for detailed consultation on the price and reimbursement process to obtain the most accurate information.

For patients who want to further reduce medication costs, overseas generic drugs provide more choices. Currently, the generic version of selinesol produced in Laos is attracting attention due to its affordable price. The price of a box of the Laos generic version is about more than 2,000 yuan, which is much cheaper than the domestic original drug. This version is produced by a factory that meets certain international pharmaceutical standards. The drug ingredients are basically the same as the original drug. It is an important medication alternative for patients with limited economic conditions.

Although the price advantage of generic drugs is obvious, patients should still be cautious when choosing and be sure to purchase through regular channels to avoid the risk of counterfeit drugs or substandard quality. Whether it is a domestic original drug or a Laotian generic version, it should be used under the guidance of a professional doctor. As an innovative therapy, selinesol provides new options for the treatment of multiple myeloma and other diseases, and its multi-channel availability also brings greater medication flexibility to patients.

Reference materials:https://www.selincro.com/